Thank you, readers! That's all from CNBCTV18.com's live market coverage on October 28, 2022. Stay tuned for other updates on our website: CNBCTV18.com.
You can follow us on Twitter: @CNBCTV18Live @CNBCTV18News
And on Facebook, LinkedIn, Instagram and Telegram
Download our mobile app for Android and iOS platforms
Global Health is not attractive to buy: Ambareesh Baliga
"Global Health is not attractive to buy at these levels. I think at these levels is fully priced and the stock was expected to list at about Rs 20-25 premium. But despite that it has moved up much beyond the expected level. So at the current level, it is fully priced and you really can't evaluate on the same lines as Apollo because that's much larger. So I think you should be quoting it at a discount to that. So at these levels I will not suggest fresh buying," says market expert Ambareesh Baliga.
Sensex and Nifty end higher driven by Kotak, HDFC twins, Infosys
-- Kotak, HDFC and HDFC Bank lift market while RIL, Bajaj Fin and Adani Ent drag
-- Metal stocks under pressure, Hindalco, JSW and Tata Steel fall two percent each
-- Kotak Bank, Coal India, HDFC, HUL, DRL, TCS are top Nifty gainers
-- Adani Group shares see a huge volatility, Adani Ent falls two percent after five percent intra-day move
-- Metropolis slides eight percent sources indicate I-T search in premises, management under scanner too
-- Apollo Tyres sees profit booking after a recent upmove, closes seven percent lower
-- Aarti Ind ends with a cut of four percent on cautious management commentary
-- Delta, Rain Ind, Muthoot Fin, Max Fin, Can Fin amongst top midcap losers
-- HAL, NBCC, Honeywell, Dalmia Bharat, LIC Hsg, Amara Raja top midcap gainers
-- Nazara Tech fails to hold gains after a positive ruling from HC on online gambling
-- Rail PSUs continue the gaining momentum, IRCON, RVNL and IRFC up 3-9 percent
-- Global Health (Medanta) makes a strong debut, ends at 417 vs issue price of 336
-- Bikaji closes at 318 against issue price of 300/sh on listing day
-- Market breadth favours declines, advance-decline ratio at 2:3
ICICI Bank decent to hold: Sharad Avasthi
"ICICI Bank, again, a decent bank to hold. But I think most of the play that has to happen with regard to improvements that can happen to the bank and improvements that can happen to the multiple have been done," says Sharad Avasthi, Head- PCG ReseSharad Avasthiarch at SMIFS. "From here onwards, the normal business trajectory would play out because the stock I believe, is already trading at 3.3-3.5 times. So there's not much scope of re-rating happening there. Considering the numbers, I think FY24 book value should be somewhere around Rs 330-340. So considering a price to book of three times Rs 1,020 could be a fair value for the stock."
Buy Karur Vysya Bank, NBCC: Rahul Sharma
Here are some recommendations by Rahul Sharma of Equity99 Advisors:
-- Buy Karur Vysya Bank for a target of Rs 115 with a stop loss at Rs 100
-- Buy NBCC for target of Rs 45-46 with a stop loss at Rs 32
Room for a correction to kick in: Rohit Srivastava
"My sense is that this rally is getting to the point where it's a little fatigued," says Rohit Srivastava, Founder & Strategist, indiacharts.com. "We are seeing a slight loss in volume specifically, if we look at the Nifty one month futures market for the last two days, volumes are down to are almost around 55-56 lakh shares traded, which is the lowest since September," he explains. "We are also not seeing participation from the broad market in general. The momentum is really slowing down, when we look at the trading volumes and the participation of stocks across the board. And so that's my near term concern, I think there's room for a correction to really kick in. And we will try to judge the size and scale of that but right now, we really want to be booking gains wherever possible, and taking a step back from the market."
Buy Kotak Mahindra Bank, UBL: Jay Thakkar
Here are two recommendations by Jay Thakkar, Marwadi Shares and Finance:
-- Buy Kotak Mahindra Bank for a target of Rs 2,030 and 2,060 with a stop loss at Rs 1,920
-- Buy UBL for a target of Rs 1,775-1,810 with a stop loss at Rs 1,650
Metropolis Healthcare stock hit as I-T department carries out searches
"I-T department has alleged Metropolis of unaccounted and concealed income and the top management, too, is under I-T scanner," sources told CNBC-TV18. (Read more)
Currency | Price | Change | %Change |
---|